Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gisslinger

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|March 22, 2001
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?T Bachleitner-Hofmann, B Gisslinger, E Grumbeck, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 13, 2000
Multifocal eosinophilic granuloma of the jaw: long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesionsI M Watzke, W Millesi, C Kermer, et al.
Annals of Hematology|October 31, 1998
Low-molecular-weight heparin-induced skin necrosisW Füreder, P A Kyrle, H Gisslinger, et al.
British Journal of Haematology|November 13, 2001
Endothelial dysfunction in patients with polycythaemia veraT Neunteufl, S Heher, T Stefenelli, et al.
Lancet (London, England)|October 27, 1990
Effect of combination chemotherapy with verapamilH Gisslinger, R Pirker, J Wallner, et al.
Acta Medica Austriaca|January 1, 1985
[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]W Linkesch, H Gisslinger, H Ludwig, et al.
Leukemia|February 1, 1990
Long-term alpha-interferon therapy in myelodysplastic syndromesH Gisslinger, A Chott, W Linkesch, et al.
British Journal of Haematology|January 1, 1994
Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-alpha N1 and in vitro studies on the specificity of the antibodiesC M Brand, L Leadbeater, R Budiman, et al.
Leukemia & Lymphoma|June 1, 1999
Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemiaM Fiegl, A Chott, H L Seewann, et al.
Leukemia|November 30, 2016
Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'H Gisslinger, G Jeryczynski, A Wölfler, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|March 22, 2001
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?T Bachleitner-Hofmann, B Gisslinger, E Grumbeck, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 13, 2000
Multifocal eosinophilic granuloma of the jaw: long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesionsI M Watzke, W Millesi, C Kermer, et al.
Annals of Hematology|October 31, 1998
Low-molecular-weight heparin-induced skin necrosisW Füreder, P A Kyrle, H Gisslinger, et al.
British Journal of Haematology|November 13, 2001
Endothelial dysfunction in patients with polycythaemia veraT Neunteufl, S Heher, T Stefenelli, et al.
Lancet (London, England)|October 27, 1990
Effect of combination chemotherapy with verapamilH Gisslinger, R Pirker, J Wallner, et al.
Acta Medica Austriaca|January 1, 1985
[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]W Linkesch, H Gisslinger, H Ludwig, et al.
Leukemia|February 1, 1990
Long-term alpha-interferon therapy in myelodysplastic syndromesH Gisslinger, A Chott, W Linkesch, et al.
British Journal of Haematology|January 1, 1994
Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-alpha N1 and in vitro studies on the specificity of the antibodiesC M Brand, L Leadbeater, R Budiman, et al.
Leukemia & Lymphoma|June 1, 1999
Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemiaM Fiegl, A Chott, H L Seewann, et al.
Leukemia|November 30, 2016
Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'H Gisslinger, G Jeryczynski, A Wölfler, et al.
Pageof 10